Analysis reveals connections between transcription factors and cancer, suggesting novel drug targets for therapy.
Background: Transcription factors (TFs) are critical regulators of gene expression, and their dysregulation is implicated in diseases like cancer. This study aims to create a comprehensive resource of TF cascades to identify potential therapeutic targets. Methods: We extracted TF interactions from the STRING database, constructed a knowledge graph using graph machine learning, and performed pathway enrichment analysis with Enrichr. Network analysis and PageRank identified influential TFs. Results: We generated 81,488 unique TF cascades, with the longest containing 62 TFs. Key TFs (e.g., MYC, TP53, STAT3) were identified, and enriched pathways included cancer-related processes. A knowledge graph and dataset were made publicly available. Conclusions: This compendium of TF cascades provides a valuable resource for understanding TF interactions and identifying novel drug targets for precision therapeutics.
No takes yet. Share an insight, caveat, or question.
Anoop Titus (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: